En 2021, solo el 33,2 % de los que iniciaron terapia con Wegovy continuaba su uso al cumplirse un ao, mientras que en el primer trimestre de 2024 esa proporcin se elev al 62,7 %
The mechanistic evidence is strong
Identify gaps in your horse's nutrition program to optimize their well-being
This review summarizes the current evidence on utilization of GLP-1 and dual GLP-1/GIP RAs in chronic weight management
Originally developed for diabetes, these medications are now widely used for weight loss because they: Help you feel full faster and longer Reduce cravings and appetite Support steady, sustainable weight loss Clinical studies show that people using GLP-1 medications lose 57 times more weight than with diet and exercise alone
Dungan, K., & DeSantis, A